CD74 and breast carcinoma: Recently, CD74 has been described as having an oncogenic role in promoting cell proliferation and preventing cell death via a macrophage migratory inhibitory factor (MIF)-dependent manner [15], as proven in breast cancer [16], renal cell carcinoma [17], colorectal cancer [18], and non-small-cell lung carcinoma [19].